AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 141 min read$CROX

SMACH THOMAS J purchased $109K of CROX (indirect holdings)

SMACH THOMAS J purchased 1,000 indirectly-held shares of Crocs, Inc. (CROX) at $109.26 ($0.11M total) on 2026-09-10.

Original reporting
SEC EDGAR · SMACH THOMAS J
Published Sep 14, 2026, 9:21 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 14, 2026, 10:12 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$CROX
Neutral
high confidence
Mentioned
$CROX
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CROXNeutralLow
01

Why it matters

The purchase is modest relative to Crocs' market cap, suggesting limited immediate price effect.

02

Market read

Routine insider purchase with minimal market impact; primarily of interest to insiders and compliance monitors.

03

What to watch

Potential upcoming product launches or seasonal demand could make the purchase more meaningful if disclosed later.

Relevance 5/10Novelty 3/10Timing: filing today

Background

SEC Form 4 filing discloses insider transactions. Directors often buy shares to signal confidence, but the amount matters.

Company-level read

Ticker impact

$CROXNeutralHigh confidence
Context

Director Thomas J. Smach bought 1,000 Crocs shares for $109,265, raising his indirect holdings to 112,063 shares.

Expected impact

Minimal short‑term impact; price may stay flat or see a slight uptick.

Evidence & confidence

The transaction size ($109k) is modest for a director and does not represent a material stake change.

Market effects

Sector

No broader sector impact; Crocs operates in consumer footwear, and a single director purchase is not sector‑wide news.

Regional

Limited to U.S. equity market; no regional ripple effect.

Global

Low global relevance; the filing is a routine insider transaction.

Counterpoint

What could challenge this read

Some traders may view any insider buying as a bullish signal, but the small size limits its significance.

Key entities

  • company
    Crocs, Inc.

    Footwear manufacturer listed on NYSE under ticker CROX.

  • person
    Thomas J. Smach

    Director of Crocs who filed the Form 4 purchase.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

CROX insider trading history →

Related articles

OCT 2
$NKEMed

Nike’s Weak First Quarter Report Ripples Across Footwear Sector

Nike reported weaker-than-expected Q1 sales and announced layoffs, causing its shares to drop 6.6% to $32.84. Competitors like Adidas and Puma saw mixed reactions, while other footwear brands and retailers experienced varied share price movements. Retailers such as Academy Sports + Outdoors and Dick’s Sporting Goods saw gains.

wwd.com2 min
SEP 27
$CROXMedAI 8/10

Crocs sues Five Below, alleging they copied the famous clogs

Crocs and Jibbitz Charms sued Five Below, alleging trademark and patent infringement for selling clogs and charms resembling Crocs' products. The lawsuit seeks damages and a permanent injunction. Five Below's net sales rose 27% year-over-year to $344 million by August, with 101 new stores opened.

spokesman.com2 min
SEP 25
$CROXMed

Crocs Sues Five Below Over Alleged Knockoff Clogs and Charms

Crocs sued Five Below for allegedly infringing on its patents and trademarks with the sale of its Juniors Charm Clog. The lawsuit, filed in Colorado, claims Five Below's clogs and charms mimic Crocs' designs, misleading consumers. Crocs seeks damages, a permanent injunction, and destruction of infringing inventory. Five Below's clogs retail for $7, while Crocs' Kids Classic Clog sells for $39.99.

news.ssbcrack.com2 min
SEP 24
$CROXMed

Crocs and Five Below are in a legal fight over a $7 shoe

Crocs is suing Five Below, alleging that its clogs and charms infringe on Crocs' trademarks and patents. The lawsuit seeks damages, a halt to sales, and destruction of inventory. Five Below reported strong financial results, with net sales up 27% and net income over $344 million. Crocs generates over $4 billion in annual sales.

aol.com2 min
SEP 24
$CROXMedAI 8/10

Crocs sues Five Below, alleging they copied the famous clogs

Crocs has sued Five Below, alleging trademark and patent infringement by selling clogs and accessories resembling Crocs' products. The lawsuit, filed in Colorado, seeks damages and a permanent injunction. Five Below's net sales increased over 27% year-over-year, with net income of $344 million as of August, according to its earnings report.

inquirer.com2 min